Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Abeona Therapeutics Inc. (ABEO) had Receiveable Turnover of 1.43 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$3.50M |
|
$-54.19M |
|
$1.60M |
|
$1.90M |
|
$50.63M |
|
$-47.13M |
|
$-7.05M |
|
$-54.19M |
|
$-54.19M |
|
$-54.19M |
|
$-54.19M |
|
$-54.19M |
|
$-54.19M |
|
$-47.13M |
|
$-43.94M |
|
21.38M |
|
21.38M |
|
$-2.53 |
|
$-2.53 |
|
| Balance Sheet Financials | |
$55.74M |
|
$3.53M |
|
$8.27M |
|
$64.00M |
|
$13.42M |
|
-- |
|
$35.75M |
|
$49.18M |
|
$14.83M |
|
$14.83M |
|
$14.83M |
|
26.52M |
|
| Cash Flow Statement Financials | |
$-37.01M |
|
$0.21M |
|
$37.06M |
|
$14.55M |
|
$14.81M |
|
$0.26M |
|
$4.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
54.14% |
|
-1346.71% |
|
-1346.71% |
|
-1255.34% |
|
-1548.23% |
|
-1548.23% |
|
$-37.14M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
|
Receiveable Turnover |
1.43 |
254.87 |
|
-365.49% |
|
-365.49% |
|
-84.67% |
|
-365.49% |
|
$0.56 |
|
$-1.74 |
|
$-1.73 |
|